Clinical Trial Update: SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) [Phase 1]

View source ↗

Summary

This is a completed Phase 1 clinical trial update for SCH-58500 in patients with fallopian tube cancer, ovarian cancer, or primary peritoneal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• SCH-58500 (SCH-58500)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Fallopian Tube Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED